Breaking News

BioConnection Raises Capital from Investors

New funding secures growth acceleration and further enhancement of quality control.

Author Image

By: Charlie Sternberg

Associate Editor

BioConnection, an independent CDMO based in The Netherlands, specialized in GMP-certified manufacturing of sterile drug products in vials and syringes, has completed a new capital raising led by the European investment company Gimv, and supported by existing shareholders Pharming Group N.V., Mibiton and BioConnection’s own management.   Financial details were not disclosed. Brabant Development Agency (BOM), one of BioConnection’s founding investors, chose to divest its shareholding...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters